Tag Archives: erufosine

Erufosine increases RhoB expression in oral squamous carcinoma cells independent of its anticancer mechanism of action

Erufosine is an ether–lipid-derived synthetic compound belonging to the group of alkylphosphocholines (APCs). This chemotherapeutic agent exhibits pronounced anti-leukemic activity without affecting the normal hematopoiesis and exerts its influence by modulating signal transduction pathways in malignant tumor